PneumRx Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 69


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $475M

PneumRx General Information


Developer of minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Corporate Office
  • 530 Logue Avenue
  • Mountain View, CA 94043
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PneumRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 07-Jan-2015 $475M 0000 00000 Completed Generating Revenue
4. Debt - General 00.00 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 04-Jan-2011 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Mar-2007 $26.8M $37.5M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Jun-2005 $10.7M $10.7M 000.00 Completed Product Development
To view PneumRx’s complete valuation and funding history, request access »

PneumRx Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series C2 0,000,000 00.000000 00.00
Series B 17,881,068 $0.001000 $0.12 $1.5 $1.5 1x $1.5 23.84%
Series A 9,900,353 $0.001000 $0.09 $1.1 $1.1 1x $1.1 13.2%
To view PneumRx’s complete cap table history, request access »

PneumRx Comparisons

HQ Location
Total Raised
Post Valuation
Developer of minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coi
Therapeutic Devices
Mountain View, CA
69 As of 2014
00000 0000-00-00
000000&0 0000


t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
00000000000 0000000
Salt Lake City, UT
00 As of 0000
00000000000 0000


onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
00000000000 0000000
San Jose, CA
00 As of 0000
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PneumRx Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Light Line Medical Venture Capital-Backed Salt Lake City, UT 00 0000 00000000000 0000
Uptake Medical Formerly VC-backed San Jose, CA 00 000.00 000000&0 000.00
Spinal Simplicity Venture Capital-Backed Overland Park, KS 00 0000 00000000000 0000
EndoGastric Solutions Formerly VC-backed Redmond, WA 00 00000 000000&0 00000
Boston Scientific Corporation Marlborough, MA 00000 00.00 000000000 00 00.00
To view PneumRx’s complete competitors history, request access »

PneumRx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PneumRx Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adams Street Partners PE/Buyout Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Endeavour Vision Venture Capital Minority 000 0000 000000 0
Forbion Venture Capital Minority 000 0000 000000 0
KBL Healthcare Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

PneumRx Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Broncus Medical 06-Jun-2012 00000 0000 Diagnostic Equipment
Broncus Technologies (Emphysema Assets) 22-May-2012 Merger/Acquisition Therapeutic Devices
To view PneumRx’s complete investments and acquisitions history, request access »

PneumRx Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Broncus Medical 06-Jun-2012 00000 00000 00 Completed
  • 3 buyers
To view PneumRx’s complete exits history, request access »

PneumRx FAQs

  • When was PneumRx founded?

    PneumRx was founded in 2004.

  • Who is the founder of PneumRx?

    Mark Mathis and Erin McGurk are the founders of PneumRx.

  • Where is PneumRx headquartered?

    PneumRx is headquartered in Mountain View, CA.

  • What is the size of PneumRx?

    PneumRx has 69 total employees.

  • What industry is PneumRx in?

    PneumRx’s primary industry is Therapeutic Devices.

  • Is PneumRx a private or public company?

    PneumRx is a Private company.

  • What is the current valuation of PneumRx?

    The current valuation of PneumRx is 00000.

  • What is PneumRx’s current revenue?

    The current revenue for PneumRx is 00000.

  • How much funding has PneumRx raised over time?

    PneumRx has raised $73M.

  • Who are PneumRx’s investors?

    Adams Street Partners, Alta Partners, Endeavour Vision, Forbion, and KBL Healthcare Ventures are 5 of 11 investors who have invested in PneumRx.

  • Who are PneumRx’s competitors?

    Light Line Medical, Uptake Medical, Spinal Simplicity, EndoGastric Solutions, and Boston Scientific are some of the 6 competitors of PneumRx.

  • When was PneumRx acquired?

    PneumRx was acquired on 07-Jan-2015.

  • Who acquired PneumRx?

    PneumRx was acquired by BTG.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »